27
Views
0
CrossRef citations to date
0
Altmetric
Review

Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review

, , , , , , , , & show all
Received 16 Oct 2023, Accepted 03 Apr 2024, Published online: 15 Apr 2024

References

  • Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581–585. doi: 10.1016/S0140-6736(99)01312-4
  • Hoy D, Brooks P, Blyth F, et al. The epidemiology of low back pain. Best Pract Res Clin Rheumatol. 2010;24(6):769–781. doi: 10.1016/j.berh.2010.10.002
  • Freburger JK, Holmes GM, Agans RP, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169(3):251–258. doi: 10.1001/archinternmed.2008.543
  • Manchikanti L. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician. 2009;4(12):E35–E70. doi: 10.36076/ppj.2009/12/E35
  • Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: data from the 2009–2010 National health and nutrition examination survey. Arthritis Care Res. 2016;68(11):1688–1694. doi: 10.1002/acr.22890
  • Manfrè L, Van Goethem J. Low Back Pain. In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Dis Brain Head Neck Spine 2020–2023 Diagn Imaging [Internet]. Cham (CH): Springer; 2020. [cited 2023 Jul 12]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554336/
  • Beall DP, Wilson GL, Bishop R, et al. VAST clinical trial: safely supplementing tissue lost to degenerative disc disease. Int J Spine Surg. 2020;14:239–253.
  • Verrills P, Nowesenitz G, Barnard A. Prevalence and characteristics of discogenic pain in tertiary practice: 223 consecutive cases utilizing lumbar discography. Pain Med Malden Mass. 2015;16(8):1490–1499. doi: 10.1111/pme.12809
  • Fujii K, Yamazaki M, Kang JD, et al. Discogenic back pain: literature review of definition, diagnosis, and treatment. JBMR Plus. 2019;3:e10180.
  • Waxenbaum JA, Reddy V, Futterman B. Anatomy, back, intervertebral discs. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [cited 2023 Jul 12]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470583/
  • Calodney A, Buchalter J. Epidemiology and etiology of discogenic pain [Internet]. Anesth Key 2016. [cited 2023 Oct 3]. Available from: https://aneskey.com/epidemiology-and-etiology-of-discogenic-pain/.
  • Mohd Isa IL, Teoh SL, Mohd nor NH, et al. Discogenic low back pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci. 2023;24(1):208. doi: 10.3390/ijms24010208.
  • Chan WCW, Sze KL, Samartzis D, et al. Structure and biology of the intervertebral disk in health and disease. Orthop Clin North Am. 2011;42(4):447–464. vii. doi: 10.1016/j.ocl.2011.07.012
  • Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine. 2006;31(18):2151. doi: 10.1097/01.brs.0000231761.73859.2c
  • Frost BA, Camarero-Espinosa S, Foster EJ. Materials for the spine: anatomy, problems, and solutions. Materials. 2019;12(2):253. doi: 10.3390/ma12020253
  • Battié MC, Videman T, Parent E. Lumbar disc degeneration: epidemiology and genetic influences. Spine. 2004;29(23):2679. doi: 10.1097/01.brs.0000146457.83240.eb
  • VAST trial evaluates injectable allograft disc tissue to relieve chronic back pain [Internet]. Endovasc Today Bryn Mawr Communications. [cited 2023 Jun 24]. Available from: https://evtoday.com/news/vast-trial-evaluates-injectable-allograft-disc-tissue-to-relieve-chronic-back-pain
  • Urban JP, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120–130. doi: 10.1186/ar629
  • Teraguchi M, Yoshimura N, Hashizume H, et al. Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: the Wakayama spine study. Osteoarthritis Cartilage. 2014;22(1):104–110. doi: 10.1016/j.joca.2013.10.019
  • Vadalà G, Russo F, Di Martino A, et al. Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering. J Tissue Eng Regen Med. 2015;9(6):679–690. doi: 10.1002/term.1719
  • Zhang F, Wang S, Li B, et al. Intradiscal injection for the management of low back pain. JOR Spine. 2021;5(1):e1186. doi: 10.1002/jsp2.1186
  • Fernandez-Moure J, Moore CA, Kim K, et al. Novel therapeutic strategies for degenerative disc disease: review of cell biology and intervertebral disc cell therapy. SAGE Open Med. 2018;6:2050312118761674. doi: 10.1177/2050312118761674
  • Xin J, Wang Y, Zheng Z, et al. Treatment of intervertebral disc degeneration. Orthop Surg. 2022;14(7):1271–1280. doi: 10.1111/os.13254
  • Donnally CJ III, Hanna A, Varacallo M. Lumbar Degenerative Disk Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [cited 2023 Oct 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK448134/
  • Yamazaki M, Kang JD, Risbud MV, et al. Discogenic back pain: literature review of definition, diagnosis, and treatment. JBMR Plus. 2019;3(5):e10180. doi: 10.1002/jbm4.10180
  • Kim HS, Wu PH, Jang I-T. Lumbar degenerative disease part 1: anatomy and pathophysiology of intervertebral discogenic pain and radiofrequency ablation of basivertebral and sinuvertebral nerve treatment for chronic discogenic back pain: a prospective case series and review of literature. Int J Mol Sci. 2020;21:1483.
  • Urban JPG, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120–130. doi: 10.1186/ar629
  • Mehrkens A, Müller AM, Valderrabano V, et al. Tissue engineering approaches to degenerative disc disease–a meta-analysis of controlled animal trials. Osteoarthritis Cartilage. 2012;20(11):1316–1325. doi: 10.1016/j.joca.2012.06.001
  • Mern DS, Walsen T, Beierfuß A, et al. Animal models of regenerative medicine for biological treatment approaches of degenerative disc diseases. Exp Biol Med (Maywood). 2021;246(4):483–512. doi: 10.1177/1535370220969123
  • Antoniou J, Steffen T, Nelson F, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996;98(4):996–1003. doi: 10.1172/JCI118884
  • Choi Y-S. Pathophysiology of degenerative disc disease. Asian Spine J. 2009;3(1):39–44. doi: 10.4184/asj.2009.3.1.39
  • Vergroesen P-P, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 2015;23(7):1057–1070. doi: 10.1016/j.joca.2015.03.028
  • Sivan SS, Hayes AJ, Wachtel E, et al. Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc. Eur Spine J. 2014;23(S3):344–353. doi: 10.1007/s00586-013-2767-8
  • Xu J, Xie G, Yang W, et al. Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes. Cell Cycle. 2021;20(15):1487–1499. doi: 10.1080/15384101.2021.1949839
  • Pennicooke B, Moriguchi Y, Hussain I, et al. Biological treatment approaches for degenerative disc disease: a review of clinical trials and future directions. Cureus. 2016 [cited 2023 Oct 4];8. Available from: https://www.cureus.com/articles/4056-biological-treatment-approaches-for-degenerative-disc-disease-a-review-of-clinical-trials-and-future-directions.
  • Meisel HJ, Siodla V, Ganey T, et al. Clinical experience in cell-based therapeutics: disc chondrocyte transplantation: a treatment for degenerated or damaged intervertebral disc. Biomol Eng. 2007;24(1):5–21. doi: 10.1016/j.bioeng.2006.07.002
  • Tschugg A, Diepers M, Simone S, et al. A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of phase I-a short report. Neurosurg Rev. 2017;40:155–162.
  • Tschugg A, Michnacs F, Strowitzki M, et al. A prospective multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disc plus autologous disc chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disc to avoid secondary disease: study protocol for a randomized controlled trial. Trials. 2016;17(1):108. doi: 10.1186/s13063-016-1239-y
  • Adkisson HD, Martin JA, Amendola RL, et al. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med. 2010;38(7):1324–1333. doi: 10.1177/0363546510361950
  • Urits I, Capuco A, Sharma M, et al. Stem cell therapies for treatment of discogenic low back pain: a comprehensive review. Curr Pain Headache Rep. 2019;23(9):65. doi: 10.1007/s11916-019-0804-y
  • Gomez-Ruiz V, Blanco JF, Villarón EM, et al. Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial. Stem Cell Res Ther. 2023;14(1):78. doi: 10.1186/s13287-023-03298-4
  • Campus Bio-Medico University. Intervertebral disc regeneration mediated by autologous mesenchymal stem/stromal cells intradiscal injection: a phase IIB randomized clinical trial - DREAM Trial[Internet]. clinicaltrials.gov; 2021 [cited 2022 Dec 31]. Available from: https://clinicaltrials.gov/study/NCT05066334. Report No. NCT05066334.
  • Soufi KH, Castillo JA, Rogdriguez FY, et al. Potential role for stem cell regenerative therapy as a treatment for degenerative disc disease and low back pain: a systematic review. Int J Mol Sci. 2023;24(10):8893. doi: 10.3390/ijms24108893
  • Amirdelfan K, Bae H, McJunkin T, et al. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J Off J North Am Spine Soc. 2021;21(2):212–230. doi: 10.1016/j.spinee.2020.10.004
  • Song K, Gu T, Shuang F, et al. Adipose-derived stem cells improve the viability of nucleus pulposus cells in degenerated intervertebral discs. Mol Med Rep. 2015;12(3):4664–4668. doi: 10.3892/mmr.2015.3895
  • Hunter CW, Guyer R, Froimson M, et al. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial. Pain Manag. 2022;12(3):301–311. doi: 10.2217/pmt-2021-0078
  • Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar intradiskal platelet-rich plasma (prp) injections: a prospective, double-blind, randomized controlled study. PM&R. 2016;8(1):1–10. doi: 10.1016/j.pmrj.2015.08.010
  • Dregalla RC, Uribe Y, Bodor M. Human mesenchymal stem cells respond differentially to platelet preparations and synthesize hyaluronic acid in nucleus pulposus extracellular matrix. Spine J Off J North Am Spine Soc. 2020;20(11):1850–1860. doi: 10.1016/j.spinee.2020.06.011
  • Chujo T, An HS, Akeda K, et al. Effects of growth differentiation factor-5 on the intervertebral disc−In vitro bovine study and in vivo rabbit disc degeneration model study. Spine. 2006;31(25):2909. doi: 10.1097/01.brs.0000248428.22823.86
  • Study Details. A multicenter, randomized, double-blind, placebo controlled, clinical trial to evaluate the safety, tolerability and preliminary effectiveness of 2 doses of intradiscal rhgdf-5 (single administration) for the treatment of early stage lumbar disc degeneration. ClinicalTrials.gov. [Internet]. [cited 2023 Oct 5]. Available from: https://clinicaltrials.gov/study/NCT01124006.
  • Intervertebral disc regeneration mediated by intradiscal injection of autologous mesenchymal stem cells: a phase IIB randomized clinical trial [Internet]. UCBM. [cited 2023 Oct 9]. Available from: https://www.unicampus.it/en/research-project/intervertebral-disc-regeneration-mediated-by-intradiscal-injection-of-autologous-mesenchymal-stem-cells-phase-IIb-randomized-clinical-trial-88021/.
  • Study Details. A study comparing the safety and effectiveness of cartilage cell injected into the lumbar disc as compared to a placebo. ClinicalTrials.gov [Internet]. [cited 2024 Feb 12]. Available from: https://clinicaltrials.gov/study/NCT01771471.
  • Study Details. Platelet-rich Plasma for Low Back Pain. ClinicalTrials.gov [Internet]. [cited 2024 Feb 12]. Available from: https://www.clinicaltrials.gov/study/NCT03197415.
  • Champlin R. Selection of autologous or allogeneic transplantation. Holl-Frei Cancer Med 6th Ed [Internet] 2003. cited 2023 Oct 5]. Available from. https://www.ncbi.nlm.nih.gov/books/NBK12844/.
  • Sakai D, Schol J. Cell therapy for intervertebral disc repair: clinical perspective. J Orthop Transl. 2017;9:8–18. doi: 10.1016/j.jot.2017.02.002
  • Nomura T, Mochida J, Okuma M, et al. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res Internet. 2001;389:94–101. doi: 10.1097/00003086-200108000-00015
  • Katsuura A, Hukuda S. Experimental study of intervertebral disc allografting in the dog. Spine. 1994;19(21):2426–2432. doi: 10.1097/00007632-199411000-00011
  • Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368–2383. doi: 10.1016/S0140-6736(18)30489-6
  • Schwind J, Learman K, O’Halloran B, et al. Different minimally important clinical difference (MCID) scores lead to different clinical prediction rules for the Oswestry disability index for the same sample of patients. J Man Manip Ther. 2013;21(2):71–78. doi: 10.1179/2042618613Y.0000000028

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.